Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from PainChek Ltd ( (AU:PCK) ) is now available.
PainChek Ltd has appointed Sasha Grant as Head of Growth for its PainChek Infant App, aiming to scale up and roll out the app more effectively. Grant, known for her success with WikiCamps, is expected to enhance the app’s market presence and user experience. The PainChek Infant App, a unique AI-powered pain assessment tool for infants, has a potential market value of A$15 billion annually. Recent developments include technical updates, consumer feedback integration, and marketing strategy refinements, with expectations for increased downloads and revenue through improved registration processes and partnerships.
More about PainChek Ltd
PainChek Ltd is a developer of AI-powered pain assessment and monitoring applications. The company’s primary product, the PainChek Infant App, is a regulatory-cleared tool designed to assess pain in infants using facial feature analysis. The app is available on both Apple and Google Play stores and targets a significant market of preverbal children globally.
Average Trading Volume: 4,528,021
Technical Sentiment Signal: Buy
Current Market Cap: A$111.9M
See more insights into PCK stock on TipRanks’ Stock Analysis page.